COST

977.71

+1.05%↑

155.36

+1.42%↑

64.11

+2.82%↑

93.12

+1.34%↑

SYY

84.6

+2.2%↑

COST

977.71

+1.05%↑

155.36

+1.42%↑

64.11

+2.82%↑

93.12

+1.34%↑

SYY

84.6

+2.2%↑

COST

977.71

+1.05%↑

155.36

+1.42%↑

64.11

+2.82%↑

93.12

+1.34%↑

SYY

84.6

+2.2%↑

COST

977.71

+1.05%↑

155.36

+1.42%↑

64.11

+2.82%↑

93.12

+1.34%↑

SYY

84.6

+2.2%↑

COST

977.71

+1.05%↑

155.36

+1.42%↑

64.11

+2.82%↑

93.12

+1.34%↑

SYY

84.6

+2.2%↑

Home・Aktien・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Geschlossen

BrancheKonsumgüter defensiv

7.97 -6.46

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

7.79

Max

8.48

Schlüsselkennzahlen
By Trading Economics
Einkommen	-7.9M -10M
Verkäufe	-5.3M 31M
Gewinnspanne	-32.116
Angestellte	406

Dividenden
By Dow Jones
Nächstes Ergebnis	6. Feb. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	31M 272M
Vorheriger Eröffnungskurs	14.43
Vorheriger Schlusskurs	7.97

Nachrichtenstimmung

By Acuity

50%

55 / 133 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

3. Feb. 2026, 23:11 UTC

Wichtige Markttreiber

Akquisitionen, Fusionen, Übernahmen

Silicon Laboratories Shares Up On Report of $7 Billion Texas Instruments Acquisition Deal

3. Feb. 2026, 23:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3. Feb. 2026, 23:50 UTC

Market Talk

Nikkei May Decline After Hitting All-Time High -- Market Talk

3. Feb. 2026, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Technical Correction -- Market Talk

3. Feb. 2026, 23:41 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Makes AI Play With $10.9B Asia Data-Center Deal

3. Feb. 2026, 23:38 UTC

Ergebnisse

AMD Sales Climb on Help From Data-Center Business -- Update

3. Feb. 2026, 23:29 UTC

Akquisitionen, Fusionen, Übernahmen

KKR-Consortium Deal in STT GDC Is One of the Largest Digital-Infrastructure Transactions in Southeast Asia

3. Feb. 2026, 23:27 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix, Warner Defend Proposed Deal in Senate Hearing -- WSJ

3. Feb. 2026, 23:25 UTC

Akquisitionen, Fusionen, Übernahmen

KKR-Consortium Expects Deal to Close by Early 2H of 2026

3. Feb. 2026, 23:23 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Consortium With Singtel to Own 75% and 25% Stake in ST Telemedia Global Data Centres

3. Feb. 2026, 23:22 UTC

Akquisitionen, Fusionen, Übernahmen

KKR-Led Consortium to Buy Singapore-Based Global Data-Center Provider Valued at S$13.8B

3. Feb. 2026, 23:19 UTC

Market Talk

Australia Gold Miners Tipped to Rally Higher -- Market Talk

3. Feb. 2026, 23:19 UTC

Market Talk

Global Equities Roundup: Market Talk

3. Feb. 2026, 22:56 UTC

Wichtige Markttreiber

Akquisitionen, Fusionen, Übernahmen

Silicon Laboratories Shares Up On Report of $7B Texas Instruments Acquisition Deal

3. Feb. 2026, 22:40 UTC

Ergebnisse

Amdocs Extends Collaboration With T-Mobile

3. Feb. 2026, 22:39 UTC

Ergebnisse

Amdocs 1Q Adj EPS $1.81

3. Feb. 2026, 22:39 UTC

Ergebnisse

Amdocs 1Q Rev $1.16B

3. Feb. 2026, 22:39 UTC

Ergebnisse

Amdocs 1Q EPS $1.45 >

3. Feb. 2026, 22:38 UTC

Ergebnisse

Amdocs: Shimie Hortig to Succeed Shuky Sheffer as President and CEO, Effective March 31

3. Feb. 2026, 22:30 UTC

Akquisitionen, Fusionen, Übernahmen

Bob Iger's Second Time as CEO Wasn't Great for the Stock. He Still Leaves Behind A Strong Legacy. -- Barrons.com

3. Feb. 2026, 22:22 UTC

Akquisitionen, Fusionen, Übernahmen

Texas Instruments Nearing $7B Deal for Silicon Laboratories, Sources Tell FT

3. Feb. 2026, 22:14 UTC

Ergebnisse

AMD Expects to Scale AI Business to Tens of Billions in Annual Sales in 2027, CEO Says

3. Feb. 2026, 22:13 UTC

Ergebnisse

AMD Expects Data-Center Unit Sales to Jump More Than 60% a Year Over Next Three to Five Years, CEO Says

3. Feb. 2026, 22:12 UTC

Ergebnisse

AMD in Talks With Several Companies About At-Scale, Multi-Year Chip Deployments, CEO Says

3. Feb. 2026, 22:10 UTC

Ergebnisse

AMD CEO: Eight of 10 Biggest AI Companies Use Instinct Chip to Power Production Workloads

3. Feb. 2026, 22:10 UTC

Ergebnisse

Blackstone Stock, Alternative Managers, BDCs Dive as Software Woes Infect Private Credit -- Barrons.com

3. Feb. 2026, 22:10 UTC

Market Talk

Key Drivers Underpinning Shaw's Bullish View of Gold Intact -- Market Talk

3. Feb. 2026, 22:10 UTC

Ergebnisse

AMD CEO: Enterprises Are Modernizing Data Centers to Have Compute Needed for New AI Workflows

3. Feb. 2026, 22:09 UTC

Ergebnisse

AMD CEO: Hyperscalers Expanding Infrastructure to Meet Growing Cloud-Services Demand in AI

3. Feb. 2026, 22:09 UTC

Ergebnisse

AMD CEO: Demand Accelerated Across Data Center, Gaming and PC

Peer-Vergleich

Kursveränderung

Lifecore Biomedical Inc Prognose

Rating-Konsens

By TipRanks

Buy

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lifecore Biomedical Inc – Dist abgegeben haben.

Stimmung

By Acuity

55 / 133 Ranking in Konsumgüter defensiv

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.